Overview

Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol

Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Exploration of antipsoriatic effects of UVB-therapy +/- CYP-inhibitor Ketokonazol on affected psoriatic skin
Phase:
Phase 2
Details
Lead Sponsor:
Technische Universität Dresden
Treatments:
Calcitriol
Dihydroxycholecalciferols
Ketoconazole